Heron Therapeutics (HRTX)
1.7850 +0.0550 (+3.18%) 12:45 ET [NASDAQ]
1.7800 x 300 1.7900 x 205
Realtime by (Cboe BZX)
1.7800 x 300 1.7900 x 205
Realtime 1.7300 unch (unch) 08:53 ET
for Mon, Feb 24th, 2025
Results
download Want to compare other data? Select FieldsSymbol | HRTX | AQST | RCEL | ||
Company | Heron Therapeutics | Aquestive Therapeutics Inc | Avita Medical Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.7300 | 3.04 | 9.75 | ||
High | 1.7600 | 3.06 | 9.82 | ||
Low | 1.6908 | 2.91 | 9.56 | ||
Last | 1.7850 | 3.05 | 9.76 | ||
Change | +0.0550 | +0.04 | +0.01 | ||
% Change | +3.18% | +1.16% | +0.10% | ||
Volume | 468,291 | 832,077 | 64,350 | ||
20-Day Average Volume | 1,134,485 | 2,048,366 | 185,924 | ||
Previous Close | 1.7300 | 3.01 | 9.75 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 1.7298 | 3.09 | 9.37 | ||
20-Day Raw Stochastic | 42.19% | 20.39% | 42.71% | ||
20-Day Relative Strength | 52.93% | 43.12% | 47.09% | ||
Weighted Alpha | -24.94 | -31.03 | -15.74 | ||
Today's Opinion | 8% Buy | 72% Sell | 32% Sell | ||
Previous Opinion | 8% Sell | 72% Sell | 32% Sell | ||
Last Month's Opinion | 24% Sell | 72% Sell | 24% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -2.53% since 02/14/25 | -8.89% since 02/14/25 | -9.18% since 02/14/25 | ||
Low | 1.6300 on 02/19/25 | 2.91 on 02/24/25 | 9.53 on 02/21/25 | ||
High | 1.8307 on 02/18/25 | 3.37 on 02/18/25 | 11.00 on 02/18/25 | ||
1-Month | |||||
%Chg | -5.19% since 01/24/25 | -2.10% since 01/24/25 | +3.00% since 01/24/25 | ||
Low | 1.6000 on 02/12/25 | 2.87 on 02/03/25 | 8.37 on 02/12/25 | ||
High | 1.9200 on 01/27/25 | 3.63 on 02/13/25 | 11.25 on 02/14/25 | ||
3-Month | |||||
%Chg | +62.15% since 11/22/24 | -33.66% since 11/22/24 | -28.04% since 11/22/24 | ||
Low | 1.0700 on 11/26/24 | 2.87 on 02/03/25 | 8.35 on 01/23/25 | ||
High | 1.9900 on 12/04/24 | 5.28 on 12/02/24 | 14.16 on 01/07/25 | ||
6-Month | |||||
%Chg | -11.03% since 08/23/24 | -32.17% since 08/23/24 | +2.78% since 08/23/24 | ||
Low | 1.0400 on 11/12/24 | 2.87 on 02/03/25 | 8.22 on 09/04/24 | ||
High | 2.1500 on 10/04/24 | 5.80 on 10/30/24 | 14.16 on 01/07/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 263,124 | 274,446 | 255,626 | ||
Shares Outstanding, K | 152,095 | 91,178 | 26,218 | ||
Annual Sales | 127,040,000 | 50,580,000 | 64,250,000 | ||
Annual Net Income | -110,560,000 | -7,870,000 | -61,850,000 | ||
Last Quarter Sales | 32,810,000 | 13,540,000 | 18,410,000 | ||
Last Quarter Net Income | -4,850,000 | -11,510,000 | -11,590,000 | ||
60-Month Beta | 1.60 | 2.67 | 1.55 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.03 on 11/12/24 | -0.13 on 11/04/24 | -0.44 on 02/13/25 | ||
Latest Earnings Date | 02/27/25 | 03/05/25 | 02/13/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |